Details for Patent: 9,622,983
✉ Email this page to a colleague
Which drugs does patent 9,622,983 protect, and when does it expire?
Patent 9,622,983 protects TROKENDI XR and is included in one NDA.
This patent has eleven patent family members in eight countries.
Summary for Patent: 9,622,983
| Title: | Sustained-release formulations of topiramate |
| Abstract: | Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. |
| Inventor(s): | Liang; Likan (Boyds, MD), Wang; Hua (Clarksville, MD), Bhatt; Padmanabh P. (Rockville, MD), Vieira; Michael L. (Gaithersburg, MD) |
| Assignee: | Supernus Pharmaceutcals, Inc. (Rockville, MD) |
| Application Number: | 15/259,856 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,622,983 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,622,983
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Supernus Pharms | TROKENDI XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 201635-001 | Aug 16, 2013 | AB1 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | USE OF TROKENDI XR FOR PROPHYLACTIC TREATMENT OF MIGRAINE | ⤷ Sign Up | ||
| Supernus Pharms | TROKENDI XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 201635-001 | Aug 16, 2013 | AB1 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | USE OF TROKENDI XR FOR THE TREATMENT OF EPILEPSY | ⤷ Sign Up | ||
| Supernus Pharms | TROKENDI XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 201635-002 | Aug 16, 2013 | AB1 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | USE OF TROKENDI XR FOR PROPHYLACTIC TREATMENT OF MIGRAINE | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,622,983
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2007319141 | ⤷ Sign Up | |||
| Canada | 2618240 | ⤷ Sign Up | |||
| Germany | 07870164 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
